A Phase I Study of NTQ1062 in Chinese Patients With Advanced Solid Tumors
Clinical trial NCT06172309 · COMPLETED
Trial details
- NCT number
- NCT06172309
- Sponsor
- Nanjing Chia-tai Tianqing Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-24
- Primary completion
- 2024-04-20
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.